Back10x Genomics Overview
10x Genomics Inc - Ordinary Shares - Class A

10x Genomics Target Price

Analysts' 12-month price predictions for TXG.

Get informed when a big investor buys or sells

+ Follow

Share Price

$45.79

Average Target Price

$32.2529.6% downside

4 analysts in the last 4 months

High: $40 | Low: $22

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-09Morgan StanleyKallum Titchmarsh$3719.2% downsideOpen
2026-06-24BarclaysLuke Sergott$4012.6% downsideOpen
2026-05-12Morgan Stanley$2252% downsideOpen
2026-04-14Barclays$3034.5% downsideOpen
2026-03-02Stifel NicolausDaniel Arias$2545.4% downsideOpen
2026-02-20UBS$2056.3% downsideOpen
2026-02-13Deutsche Bank$1762.9% downsideOpen
2026-02-13Stifel Nicolaus$2056.3% downsideOpen
2026-02-13Canaccord GenuityKyle Mikson$2252% downsideOpen
2026-01-12Needham$2154.1% downsideOpen
2025-12-22Canaccord Genuity$2056.3% downsideOpen
2025-12-15Barclays$2252% downsideOpen
2025-12-01Morgan StanleyKallum Titchmarsh$2056.3% downsideOpen
2025-08-11Canaccord GenuityKyle Mikson$1665.1% downsideOpen
2025-08-08UBSDan Leonard$1371.6% downsideOpen
2025-08-08Deutsche BankJustin Bowers$1469.4% downsideOpen
2024-08-13Morgan StanleyTejas Savant$460.5% upsideOpen
2024-07-23Canaccord GenuityKyle Mikson$3230.1% downsideOpen
2024-07-10Deutsche BankJustin Bowers$2545.4% downsideOpen
2024-06-28BarclaysLuke Sergott$2447.6% downsideOpen
2024-06-03JefferiesTycho Peterson$2447.6% downsideOpen
2024-05-01BarclaysLuke Sergott$3621.4% downsideOpen
2024-04-10BarclaysLuke Sergott$451.7% downsideOpen
2022-12-14Deutsche Bank$509.2% upsideOpen